EPISODE · Jul 30, 2025 · 3 MIN
GSK葛兰素史克豪掷最多120亿美元，与中国恒瑞达成重磅合作协议 -- 250728
from 生物科技 · host Rei
英国制药巨头GSK与中国恒瑞医药签署重磅协议，计划合作推进最多12款创新药物，涵盖呼吸、免疫和肿瘤三大领域，总金额最高达120亿美元。核心项目包括PDE3/4抑制剂HRS-9821，用于治疗慢阻肺，并将加入GSK成熟的吸入装置平台。本期带你深入解析这场全球瞩目的“中外创新绑定”，它意味着什么？谁将真正受益？又为何说它标志着中国创新药正在全面融入全球主流市场？
Embed this episode
Ready to play
GSK葛兰素史克豪掷最多120亿美元，与中国恒瑞达成重磅合作协议 -- 250728
0:00
3:25
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of 生物科技?
This episode is 3 minutes long.
When was this 生物科技 episode published?
This episode was published on July 30, 2025.
Can I download this 生物科技 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!